In this study, we demonstrated that LCN2 was aberrantly expressed in GC and negatively correlated with tumor grade and poor prognosis in patients with GC by combining the results of our previous scRNA-seq analysis data with information from database and our clinical cohort. Here, LCN2 is linked to neoplasm.